EraBiotech



Welcome
News
Technology
Licensing
Investor Information
Careers
Contact

Know more about Zera®
 
Detail / See the document


Discover StorPro organelles
Welcome to the bioproductivity company!

ERA Biotech develops and implements next-generation, cell-based biomanufacturing technologies. Our Zera® and StorPro® tools enable performance gains in most standard eukaryotic culture systems used today for production of protein drugs, enzymes and other biological products.

Zera® assembler peptides and StorPro® designed storage organelles are true “disruptive” technologies that improve the way recombinant proteins are produced and purified. They:
  • enable difficult-to-express proteins (allowing the accumulation of normally labile and cytotoxic peptide/proteins)
  • simplify and accelerate downstream processing
  • make possible high product titers in upstream production
  • create novel bioencapsulation and biopresentations options for vaccines and pharmaceuticals
Product opportunities enabled by ERA Biotech include biopharmaceuticals, oral and injectable vaccines, highly potent enzymes, and other protein-based applicationsin the health, industrial, bioenergy and nutrition sectors.


To receive e-mail updates on upcoming events from ERA Biotech please provide your e-mail address below and click on "Subscribe".
   Subscription

Latest News

September 16, 2009   
   
ERA Biotech, a bioproductivity company developing proprietary tools that improve the performance of cell-based factories, announced today that it has concluded a €3,75m ($5,3m) investment in a series B round.
July 1, 2009   
   
Several scientific positions open at ERA Biotech S.A.
February 3, 2009   
   
Dr.Stefan R. Schmidt will join ERA as VP Technology on March 2, 2009 to turn the Zera®/StoPro™ technology into a protein-production industry standard.
Results 1-3 (of 3)
First  Previous  [1]  Next  Last